All Stories

  1. Tapentadol: an effective option for the treatment of back pain [Corrigendum]
  2. Pharmacological rationale for tapentadol therapy: a review of new evidence
  3. Tapentadol: an effective option for the treatment of back pain
  4. Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer’s disease mouse model
  5. Advances in stem cell therapy for amyotrophic lateral sclerosis
  6. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome
  7. Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis
  8. TGF-β2 and TGF-β3 from cultured β-amyloid-treated or 3xTg-AD-derived astrocytes may mediate astrocyte-neuron communication
  9. l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug
  10. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS
  11. Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies
  12. Proneurogenic Effects of Trazodone in Murine and Human Neural Progenitor Cells
  13. Opiate Analgesics as Negative Modulators of Adult Hippocampal Neurogenesis: Potential Implications in Clinical Practice
  14. Novel insights into the role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells
  15. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?
  16. Cell autonomous and noncell-autonomous role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells
  17. New insights on trazodone effect in promoting neuronal differentiation of adult murine hippocampal neural progenitor cells
  18. Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice
  19. Not only a bad guy: potential proneurogenic role of the RAGE/NF-κB axis in Alzheimer's disease brain
  20. Dopamine Receptor Agonists for Protection and Repair in Parkinson's Disease: An Update
  21. Early growth response 2 (Egr-2) expression is triggered by NF-κB activation
  22. The MMP-1/PAR-1 Axis Enhances Proliferation and Neuronal Differentiation of Adult Hippocampal Neural Progenitor Cells
  23. Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling
  24. The Noradrenergic Component in Tapentadol Action Counteracts μ-Opioid Receptor–Mediated Adverse Effects on Adult Neurogenesis
  25. NF-κB Mediated Regulation of Adult Hippocampal Neurogenesis: Relevance to Mood Disorders and Antidepressant Activity
  26. Upregulation of mGlu2 Receptors via NF-κB p65 Acetylation Is Involved in the Proneurogenic and Antidepressant Effects of Acetyl-L-Carnitine
  27. High-Mobility Group Box-1 Protein and  -Amyloid Oligomers Promote Neuronal Differentiation of Adult Hippocampal Neural Progenitors via Receptor for Advanced Glycation End Products/Nuclear Factor- B Axis: Relevance for Alzheimer's Disease
  28. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain
  29. α2δ Ligands Act as Positive Modulators of Adult Hippocampal Neurogenesis and Prevent Depression-Like Behavior Induced by Chronic Restraint Stress
  30. NF-κB Proteins in Adult Neurogenesis: Relevance for Learning and Memory in Physiology and Pathology
  31. Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain
  32. F640 DISTINCT DIFFERENCES BETWEEN TAPENTADOL AND MORPHINE IN AN IN VITRO MODEL OF ADULT NEUROGENESIS
  33. Nuclear Factor  B-Dependent Neurite Remodeling Is Mediated by Notch Pathway
  34. A novel role for the Receptor for Advanced Glycation End-products in neural progenitor cells derived from adult SubVentricular Zone
  35. A-ring modifications on the triazafluorenone core structure and their mGluR1 antagonist properties
  36. Tricyclic thienopyridine–pyrimidones/thienopyrimidine–pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain
  37. Astroglial-NF-kB is a critical regulator of learning and memory and hippocampal neurogenesis in female mice
  38. Adult dorsal root ganglia sensory neurons express the early neuronal fate marker doublecortin
  39. Dopamine Receptor Agonists for Protection and Repair in Parkinsons Disease
  40. Impaired Adult Neurogenesis Associated with Short-Term Memory Defects in NF- B p50-Deficient Mice
  41. Ecdysone-Based System for Controlled Inducible Expression of Metabotropic Glutamate Receptor Subtypes 2, 5, and 8
  42. Erratum to “Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice” [Behav. Brain Res. 160 (2005) 344–355]
  43. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice
  44. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles
  45. Members of the NF-κB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain
  46. Long-lasting induction of Notch2 in the hippocampus of kainate-treated adult mice
  47. Long-lasting induction of Notch2 in the hippocampus of kainate-treated adult mice
  48. Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695
  49. Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically
  50. Induction of p53 in the glutamate-induced cell death program
  51. Contribution of NF-κB and p53 in the glutamate-induced apoptosis
  52. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage
  53. Nuclear factor-κB/Rel proteins
  54. Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway
  55. Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity?
  56. Regulation of Mouse Neuropeptide Y Y1 Receptor Gene Transcription: A Potential Role for Nuclear Factor-κB/Rel Proteins
  57. Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-kappa B Activation
  58. Interleukin-1β and Glutamate Activate the NF-κB/Rel Binding Site from the Regulatory Region of the Amyloid Precursor Protein Gene in Primary Neuronal Cultures
  59. Identification and Characterization of a κB/Rel Binding Site in the Regulatory Region of the Amyloid Precursor Protein Gene
  60. Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors
  61. Molecular mechanisms of glutamate-induced neurodegeneration
  62. Tumor necrosis factor α mediates a T cell receptor-independent induction of the gene regulatory factor NF-κB in T lymphocytes
  63. IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
  64. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes
  65. Molecular mechanisms involved in transport and release of dopamine in primary cultures of mesencephalic neurons
  66. A Novel Nuclear Factor Binds to the NF-ΚB Motif in the Interleukin-2 Enhancer
  67. Characterization of [3H]Dopamine Uptake Sites and [3H]Cocaine Recognition Sites in Primary Cultures of Mesencephalic Neurons During In Vitro Development
  68. Evidence for the involvement of distinct voltage-sensitive calcium channels in the release of 3H-dopamine from primary cultures of mesencephalic neurons
  69. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus
  70. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex